It is a class of drugs used to suppress abnormal heart rhythms (arrhythmia), such as atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation.
This report contains market size and forecasts of Anti-Arrhythmic Drug in Global, including the following market information:
Global Anti-Arrhythmic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anti-Arrhythmic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-Arrhythmic Drug include Pfizer, Hikma Pharmaceuticals, Baxter, Aurobindo Pharma, Zydus Cadila, Wockhardt, Teva Pharmaceutical, Novartis and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Arrhythmic Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Arrhythmic Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti-Arrhythmic Drug Market Segment Percentages, by Type, 2021 (%)
Oral
Parenteral
Global Anti-Arrhythmic Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anti-Arrhythmic Drug Market Segment Percentages, by Application, 2021 (%)
Hospitals
Homecare
Specialty Clinics
Others
Global Anti-Arrhythmic Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anti-Arrhythmic Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Arrhythmic Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anti-Arrhythmic Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Hikma Pharmaceuticals
Baxter
Aurobindo Pharma
Zydus Cadila
Wockhardt
Teva Pharmaceutical
Novartis
Mylan
Sun Pharmaceutical Industries
Fresenius Kabi
GSK
Lupin
Vintage Labs
Aurobindo Pharma
AstraZeneca
Dr. Reddy’s Laboratories
Johnson & Johnson Services